The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

7 Jun 2018 07:00

RNS Number : 5676Q
Sopheon PLC
07 June 2018
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

 

In conjunction with a truly exceptional financial performance in 2017, we continue to advance our strategy to be the world's leading provider of enterprise-class innovation management solutions. Our vision has consistently led the market, and this is a market that continues to evolve and demonstrate considerable growth. We delivered a very strong finish to last year, resulting in all the Group's headline financial measures exceeding market expectations by a significant margin. Revenues rose to $28.5m from $23.2m in 2016. On the back of an already strong increase in profitability in 2016, EBITDA last year reached $8.0m, up from $5.6m the year before, and profit before tax was $5.1m, compared to $3.0m the year before. Alongside a realignment of our debt position, this resulted in net assets rising to $18.6m from $10.4m the year before, and net cash rising to $9.5m from $4.2m.

 

Both volume and average value of license transactions increased compared to the year before. Towards the end of 2017 we signed substantial deals with two industry leading, blue chip, companies in the USA and in Germany and we are now in the process of implementing our Accolade® solution globally in both cases. Such customers further validate the momentum and acceptance of Accolade as an enterprise platform within the largest and most influential corporations in the world. We saw more acceptance of our SaaS (Software as a Service) offering, with three new SaaS customers signed last year, and our recurring revenue base improved to over $12m by the end of the year compared to just under $10m the year before.

 

Sopheon's market differentiation continues to be validated. Sopheon is the only vendor recognized in three different Gartner Market Guides - for Strategy Execution Management Software; Innovation Management Tools; and Strategy & Innovation Roadmapping Tools - as well as in its Magic Quadrant for Project Portfolio Management Worldwide. In our view, the capabilities called for in all of these respective reports are required to deliver on the promise of connecting strategic planning and operational execution. In addition, Sopheon was named a Leader in the 2017 Forrester Waveâ„¢: Strategic Portfolio Management Tools. Further recent market validation was recognition by Consumer Goods Technology magazine, naming Sopheon as "Best in Category" in new product development and introduction as voted by readers. Collectively, these are major strategic milestones in establishing the credentials of both the Company and our market.

 

In order to deliver on our growth strategies as described in our annual report, we are executing on ambitious investment plans across multiple functional areas to scale for growth for 2018 and beyond. Where appropriate, we are also open to consideration of targeted M&A opportunities if consistent with our goals and focused investment criteria. Alongside strategic initiatives, we remain highly driven by revenue and profit objectives, and to stand behind this ambition we have proposed a maiden dividend, to be put to the Company's shareholders at today's meeting. Remaining on the corporate theme, we were delighted with the success of our oversubscribed secondary placing completed in mid-May, which expanded our institutional shareholder base and we are grateful for the support and demand shown by certain blue chip institutional investors for the Company's shares.

 

Outlook

 

The positive momentum has continued this year, and we are signing additional new business which in turn is underpinning the performance for the year. Full year revenue visibility for 2018 from contracted business and recurring revenue streams is now up 34% at $23.5m, compared to $17.5m at this time last year - an all-time high for our mid-year AGM report. This includes the effect of several perpetual license deals and major services extensions, as well as a further major SaaS deal closed during the current quarter.

 

The Board continues to be confident and enthusiastic about the prospects of the Company, the outturn for the year and the opportunity to continue to deliver on our vision.

 

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Alice Lane (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLLFERRVIRIIT
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.